3 Things to Know About Canopy Growth Stock After Earnings

A new focus on profitability and sustainability might stop the cash burn at Canopy Growth, so the stock can see better days.

| More on:
Pot stocks are a riskier investment

Image source: Getty Images

In the aftermath of the cannabis stock bubble, we’re not left with all that much, as dashed hopes and dreams have been replaced by harsh realities. This is increasingly obvious in Canopy Growth Corp.’s (TSX:WEED) quarterly results that came out earlier this month.

Here are three things to know as we contemplate what to do next with Canopy Growth stock, a once high-flyer.

Canopy Growth is not what we expected (or hoped for)

The first thing to really wrap our heads around is the extent to which the reality of the cannabis market is different from the wildly optimistic expectations that surrounded legalization. In fact, it’s so different that this “growth” company is posting huge revenue declines. For example, Canopy posted a 28% decline in revenue in its latest quarter. Furthermore, Canadian cannabis revenue dropped 23% versus last year and 11% sequentially, as adult use has declined. Consequently, Canopy Growth stock continues to decline, which is not surprising considering these numbers. In fact, WEED stock is down 72% from its closing price at the end of 2021, and 95% from its 2018 highs.

At first glance, this might seem shocking. Yet, consider that analysts were initially estimating that the legal cannabis market size in Canada was $7+ billion – and this was being priced into the stock. Today, it’s clear that this number was wildly inaccurate for many reasons. For example, the illicit market is thriving, with an estimated 40% market share today. The legal market has had a difficult time being competitive due to taxation and the many regulatory hurdles that exist. The regulatory environment is so punitive that the sustainability of the legal sector has actually come into question.

Switching gears – consolidating into a consumer brand company

So today, Canopy Growth’s troubles reflect these sector troubles. Not only are revenues falling fast, but losses are also piling up. In response, the company has instigated broad changes. Clearly, in order to survive, something drastic has to be done. Thus, a restructuring is under way in order to realign resources with the reality of the market.

Canopy Growth is attempting to transform into a focused consumer brand company – a premium brand-focused cannabis and consumer packaged-goods company. This means consolidating, and reducing headcount and the number of products offered. It has resulted in the divestiture of the retail operations, 800 layoffs, and ultimately, a more focused company.

Two of the brands worth mentioning are BioSteel sports drinks and Storz & Bickel (S&B) premium vape offerings. BioSteel is a fast growing energy drink that has captured more than 10% market share in Canada, and 13.8% share in Ontario. So far in 2023, BioSteel’s revenue has more than doubled. Similarly, S&B vape products are seeing strong growth. In fact, revenue growth is ramping up quickly and it was a big profit contributor in the quarter.

The promise in WEED stock lies not in market size, but profitability

The growth strategy that was followed when cannabis was first legalized in Canada has been shelved as Canopy Growth has shifted the focus to profitability and sustainability. A necessary move, as the cannabis industry pie and growth that was anticipated did not come to be.

Moving forward, Canopy must focus on margins, profitability, and cash flow. The first step is to reduce its cash burn if the company wants to live to see another day. Right now, Canopy has $800 million in cash on the balance sheet. Last quarter, the company reported a $400 million cash burn.

If they can get this under control, then we can start thinking about the potential. For example, the Canadian medical cannabis market has been growing. Last quarter, revenue increased 9%.  International revenue has also been growing, with Australian sales up 200%. Finally, the S&B vaping business is a big profit contributor with gross margins of 45%, and BioSteel has the potential to achieve gross margins of 30% to 40%.

In conclusion, Canopy Growth stock is not for the faint of heart. But it never was. At least today, we know the risks that are out there and can make a more informed decision.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Karen Thomas has a position in Canopy Growth Corp. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

More on Cannabis Stocks

edit Jars of marijuana
Cannabis Stocks

Are Cannabis Stocks a Good Buy in March 2023?

Cannabis stocks like Canopy Growth Corp (TSX:WEED) are still being talked about, but are they worth buying?

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Down 26% in a Month, Is Canopy a Buy Today?

Canopy Growth Corp (TSX:WEED) is down 26% in a month. Is it time to start bottom fishing?

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

What’s Next for Aurora Cannabis Stock?

Aurora Cannabis stock is down 99% from all-time highs. Is ACB stock a buy, sell, or hold in March 2023?

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Canopy Growth Stock: Undervalued Gem or Falling Knife?

Canopy Growth remains a high-risk bet, despite falling 95% from all-time highs. Let's see why you need to avoid WEED…

Read more »

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »